BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Frost MC, Zhang L, Kim HM, Lin LA. Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic. JAMA Netw Open 2022;5:e2236298. [PMID: 36223118 DOI: 10.1001/jamanetworkopen.2022.36298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Krawczyk N, Rivera BD, King C, Dooling BC. Pandemic telehealth flexibilities for buprenorphine treatment: A synthesis of evidence and policy implications for expanding opioid use disorder care in the U.S.. [DOI: 10.1101/2023.03.16.23287373] [Reference Citation Analysis]
2 Wyse JJ, Shull S, Lindner S, Morasco BJ, Gordon AJ, Carlson KF, Korthuis PT, Ono SS, Liberto JG, Lovejoy TI. Access to Medications for Opioid Use Disorder in Rural Versus Urban Veterans Health Administration Facilities. J Gen Intern Med 2023;:1-6. [PMID: 36690913 DOI: 10.1007/s11606-023-08027-4] [Reference Citation Analysis]
3 Sugarman DE, Busch AB. Telemental health for clinical assessment and treatment. BMJ 2023;380:e072398. [PMID: 36646462 DOI: 10.1136/bmj-2022-072398] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]